VANGUARD GROUP INC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 82 filers reported holding OVID THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,391,042
+19.8%
2,966,417
+2.3%
0.00%
Q2 2023$9,509,468
+41.2%
2,899,228
+11.1%
0.00%
Q1 2023$6,735,354
+40.3%
2,610,602
+1.1%
0.00%
Q4 2022$4,802,029
+1.1%
2,581,736
+0.0%
0.00%
Q3 2022$4,748,000
-12.9%
2,580,590
+1.8%
0.00%
Q2 2022$5,450,000
-52.9%
2,535,090
-31.3%
0.00%
Q1 2022$11,580,000
+4.8%
3,687,909
+7.1%
0.00%
Q4 2021$11,051,000
-2.8%
3,442,618
+1.8%
0.00%
Q3 2021$11,364,000
-17.1%
3,382,081
-3.5%
0.00%
Q2 2021$13,706,000
-2.5%
3,505,637
+0.3%
0.00%
Q1 2021$14,056,000
+95.9%
3,496,386
+12.6%
0.00%
Q4 2020$7,174,000
-51.9%
3,105,752
+19.6%
0.00%
Q3 2020$14,903,000
-4.7%
2,596,335
+22.4%
0.00%
-100.0%
Q2 2020$15,636,000
+208.8%
2,121,632
+24.9%
0.00%
Q1 2020$5,064,000
-18.0%
1,698,971
+14.1%
0.00%
Q4 2019$6,177,000
+79.1%
1,488,529
+39.8%
0.00%
Q3 2019$3,449,000
+69.9%
1,064,568
-3.0%
0.00%
Q2 2019$2,030,000
+75.3%
1,097,614
+67.8%
0.00%
Q1 2019$1,158,000
+63.6%
654,124
+123.8%
0.00%
Q4 2018$708,000
-72.0%
292,260
-34.6%
0.00%
Q3 2018$2,533,000
-27.0%
446,770
+0.5%
0.00%
Q2 2018$3,469,000
+22.5%
444,767
+11.0%
0.00%
Q1 2018$2,832,000
-14.1%
400,530
+19.9%
0.00%
Q4 2017$3,298,000
+138.1%
334,066
+106.7%
0.00%
Q3 2017$1,385,000
+32.9%
161,657
+62.8%
0.00%
Q2 2017$1,042,00099,3170.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders